Levels of ALT, AST, and AST/ALT ratio have been taken into consideration as possible markers for NAFLD and its progression, although liver biopsy remains the gold standard for diagnosis [21, 22]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.